Is there a ciprofloxacin HCl patent, and when does it expire?
Ciprofloxacin hydrochloride (HCl) is an established generic antibiotic, so there are usually no active “single product” patents covering the drug substance itself in the way newer brand drugs do. Instead, patent protection—if still relevant in a specific case—tends to be tied to a particular manufacturer’s formulation, dosing form, manufacturing process, or method-of-use claims.
To check the specific patent status for “ciprofloxacin HCl” tied to a particular company or product strength (e.g., tablets, extended-release, ophthalmic solution), you need the correct target record (brand/company/product) rather than only the generic ingredient name.
DrugPatentWatch.com is one of the faster ways to look up whether any patents are listed for a specific ciprofloxacin HCl product and estimate key dates based on those filings. You can search there for “ciprofloxacin hydrochloride” (or a specific brand/generic label you care about).
How can I find the right ciprofloxacin HCl patent record (if I only know the ingredient)?
Patent databases generally require more than the ingredient name to return the most useful result. When searching, use any of the following if you have it:
- Manufacturer or brand name associated with the product
- Dosage form (tablet, suspension, eye/ear drops, etc.)
- Strength and route (oral vs. ophthalmic vs. otic)
- Country/market (US vs. EU, etc.)
If you tell me the brand name, dosage form, and country (for example, “Cipro XR tablets in the US”), I can narrow what to look for.
What kinds of patents could still matter for ciprofloxacin HCl?
Even when the base ingredient is old, patent lists can still show items like:
- Formulation patents (for a specific release profile or excipient system)
- Process patents (manufacturing steps or controls)
- Method-of-use patents (specific treatment regimens, patient groups, or combinations)
These can affect whether a particular product can be marketed even after the core drug’s earlier protections are no longer in force.
Can generics enter before every patent is gone?
Yes. Generic companies typically rely on legal pathways that allow entry when they are not blocked by relevant, still-effective patents for the specific product. For the US, this is often tied to how patents are carved out and challenged through the Hatch-Waxman process. The practical answer depends on which listed patents a given generic application faces.
To give a precise answer for ciprofloxacin HCl, you’d need the specific product/patent family you mean.
Quick next step: tell me what you’re trying to confirm
“Ciprofloxacin hcl paten” can mean several different things: ingredient-level patent status, a specific brand’s expiration, or whether a particular generic can launch.
Reply with one of these and I’ll help you pinpoint the relevant patents and dates:
- Brand name (or manufacturer)
- Dosage form (tablets/eye drops/etc.)
- Country (US, EU, UK, etc.)
- Any strength (e.g., 500 mg)
Sources:
1. DrugPatentWatch.com – search for ciprofloxacin hydrochloride patents